5-(4-(2-(5-Ethylpyridin-2-yl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione
CAS: 146062-49-9
Ref. 3D-WFA06249
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Informação sobre produto
- 5-[[4-[2-(5-Ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-2,4-thiazolidinedione
- 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-
- MSDC 0160
- Mitoglitazone
- CAY 10415
5-(4-(2-(5-Ethylpyridin-2-yl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione (5EPC) is a drug that inhibits tumor growth and has been used for the treatment of diabetes. It is an antidiabetic agent that binds to the receptor of soluble guanylate cyclase, which is responsible for regulating the production of cyclic guanosine monophosphate (cGMP). 5EPC has shown inhibitory effects on chronic kidney disease in patients who are not diabetic. Furthermore, it has been shown that 5EPC can be used in combination with dpp-iv inhibitors for the treatment of metabolic disorders.
Propriedades químicas
Consulta técnica sobre: 3D-WFA06249 5-(4-(2-(5-Ethylpyridin-2-yl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
